No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy

• Panagiotis Baliakas,
• Mattias Mattsson,
• Anastasia Hadzidimitriou,
• Eva Minga,
• Andreas Agathangelidis,
• Lesley-Ann Sutton,
• Lydia Scarfo,
• Zadie Davis,
• Xiao-Jie Yan,
• Karla Plevova,
• Yorick Sandberg,
• Fie J. Vojdeman,
• Tatiana Tzenou,
• Charles C. Chu,
• Silvio Veronese,
• Larry Mansouri,
• Karin E Smedby,
• Véronique Giudicelli,
• Florence Nguyen-Khac,
• Panagiotis Panagiotidis,
• Gunnar Juliusson,
• Achilles Anagnostopoulos,
• Marie-Paule Lefranc,
• Livio Trentin,
• Mark Catherwood,
• Marco Montillo,
• Carsten U. Niemann,
• Anton W. Langerak,
• Sarka Pospisilova,
• Niki Stavroyianni,
• Nicholas Chiorazzi,
• David Oscier,
• Diane F Jelinek,
• Tait Shanafelt,
• Nikos Darzentas,
• Chrysoula Belessi,
• Frederic Davi,
• Paolo Ghia,
• Richard Rosenquist,
• Kostas Stamatopoulos

Affiliations

Panagiotis Baliakas

Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden

Mattias Mattsson

Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden;Department of Hematology, Uppsala University Hospital, Sweden

Anastasia Hadzidimitriou

Institute of Applied Biosciences, Thessaloniki, Greece

Eva Minga

Institute of Applied Biosciences, Thessaloniki, Greece

Andreas Agathangelidis

Institute of Applied Biosciences, Thessaloniki, Greece;Università Vita-Salute San Raffaele, Milan, Italy;Strategic Research Program in CLL, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy

Lesley-Ann Sutton

Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden

Lydia Scarfo

Università Vita-Salute San Raffaele, Milan, Italy;Strategic Research Program in CLL, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy

Zadie Davis

Department of Haematology, Royal Bournemouth Hospital, Bournemouth, UK

Xiao-Jie Yan

The Feinstein Institute for Medical Research, Northwell Health, New York, USA

Karla Plevova

CEITEC-Central European Institute of Technology, MasarykBrno, Czech Republic;University Hospital Brno, Czech Republic

Yorick Sandberg

Department of Immunology, Erasmus MC, University Medical Center Rotterdam, the Netherlands

Fie J. Vojdeman

Department of Hematology, Rigshospitalet, Copenhagen, Denmark

Tatiana Tzenou

First Department of Propaedeutic Medicine, University of Athens, Greece

Charles C. Chu

The Feinstein Institute for Medical Research, Northwell Health, New York, USA

Silvio Veronese

Molecular Pathology Unit and Haematology Department, Niguarda Cancer Center, Niguarda Hospital, Milan, Italy

Larry Mansouri

Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden

Karin E Smedby

Department of Medicine Solna, Clinical Epidemiology Unit, Karolinska Institutet, and Hematology Center, Karolinska University Hospital, Stockholm, Sweden

Véronique Giudicelli

IMGT®, the international ImMunoGeneTics information system®, Université de Montpellier, Laboratoire d’ImmunoGénétique Moléculaire LIGM, Institut de Génétique Humaine IGH, UPR CNRS 1142, Montpellier, France

Florence Nguyen-Khac

Hematology Department and University Pierre et Marie Curie, Hopital Pitie-Salpetriere, Paris, France

Panagiotis Panagiotidis

First Department of Propaedeutic Medicine, University of Athens, Greece

Gunnar Juliusson

Lund University and Hospital Department of Hematology, Lund Stem Cell Center, Sweden

Achilles Anagnostopoulos

Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece

Marie-Paule Lefranc

IMGT®, the international ImMunoGeneTics information system®, Université de Montpellier, Laboratoire d’ImmunoGénétique Moléculaire LIGM, Institut de Génétique Humaine IGH, UPR CNRS 1142, Montpellier, France

Livio Trentin

Department of Medicine, Hematology and Clinical Immunology Branch, Padova University School of Medicine, Italy;Venetian Institute of Molecular Medicine, Padova, Italy

Mark Catherwood

Department of Hemato-Oncology, Belfast City Hospital, Belfast, UK

Marco Montillo

Molecular Pathology Unit and Haematology Department, Niguarda Cancer Center, Niguarda Hospital, Milan, Italy

Carsten U. Niemann

Department of Hematology, Rigshospitalet, Copenhagen, Denmark

Anton W. Langerak

Department of Immunology, Erasmus MC, University Medical Center Rotterdam, the Netherlands

Sarka Pospisilova

CEITEC-Central European Institute of Technology, MasarykBrno, Czech Republic;University Hospital Brno, Czech Republic

Niki Stavroyianni

Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece

Nicholas Chiorazzi

The Feinstein Institute for Medical Research, Northwell Health, New York, USA

David Oscier

Department of Haematology, Royal Bournemouth Hospital, Bournemouth, UK

Diane F Jelinek

Department of Immunology, Mayo Clinic, Rochester, MV, USA

Tait Shanafelt

Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA

Nikos Darzentas

CEITEC-Central European Institute of Technology, MasarykBrno, Czech Republic

Chrysoula Belessi

Hematology Department, Nikea General Hospital, Piraeus, Greece

Frederic Davi

Hematology Department and University Pierre et Marie Curie, Hopital Pitie-Salpetriere, Paris, France

Paolo Ghia

Università Vita-Salute San Raffaele, Milan, Italy;Strategic Research Program in CLL, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy

Richard Rosenquist

Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden;Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden

Kostas Stamatopoulos

Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden;Institute of Applied Biosciences, Thessaloniki, Greece;Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece